Sarfaraz Niazi, PhD, an adjunct professor of biopharmaceutical sciences at the University of Illinois and the University of Houston, and the founder of biosimilars companies Adello Biologics and Novel351k, Inc. He also founded the biosimilar advisory company PharmSci.
We’re all familiar with generic medications: the less expensive versions of medications that most insurance companies want us to get instead of their brand-name counterparts....
